At a glance
- Originator Roche
- Developer Nonindustrial source; Roche
- Class Antiasthmatics; Antihyperlipidaemics; Small molecules
- Mechanism of Action Apoptosis stimulants; Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Atherosclerosis; Brain cancer; Coronary artery restenosis; Transplant rejection